196170 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
196170 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company